{"organizations": [], "uuid": "46ca9e3b604d07014e31507deca1cbc12354bb50", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180116.html", "section_title": "Archive News &amp; Video for Tuesday, 16 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-tetra-bio-pharma-receives-approval/brief-tetra-bio-pharma-receives-approval-from-health-canada-of-its-phase-1-clinical-trial-with-ppp005-idUSASB0C11C", "country": "US", "domain_rank": 408, "title": "BRIEF-Tetra Bio-Pharma Receives Approval From Health Canada Of Its Phase 1 Clinical Trial With PPP005 (Cannabis Oil)", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.981, "site_type": "news", "published": "2018-01-16T21:09:00.000+02:00", "replies_count": 0, "uuid": "46ca9e3b604d07014e31507deca1cbc12354bb50"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-tetra-bio-pharma-receives-approval/brief-tetra-bio-pharma-receives-approval-from-health-canada-of-its-phase-1-clinical-trial-with-ppp005-idUSASB0C11C", "ord_in_thread": 0, "title": "BRIEF-Tetra Bio-Pharma Receives Approval From Health Canada Of Its Phase 1 Clinical Trial With PPP005 (Cannabis Oil)", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-tetra bio-pharma receives approval from health canada", "sentiment": "negative"}, {"name": "tetra bio pharma inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 16 (Reuters) - Tetra Bio Pharma Inc:\n* TETRA BIO-PHARMA RECEIVES APPROVAL FROM HEALTH CANADA OF ITS PHASE 1 CLINICAL TRIAL WITH PPP005 (CANNABIS OIL)\n* TETRA BIO PHARMA - RECEIVED NO OBJECTION LETTER FROM THERAPEUTIC PRODUCTS DIRECTORATE HEALTH CANADA OF ITS PHASE 1 CLINICAL TRIAL WITH PPP005 (CANNABIS OIL) Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-16T21:09:00.000+02:00", "crawled": "2018-01-17T19:46:20.000+02:00", "highlightTitle": ""}